Floatz logo

Therapeutic Asset Ratings

220 results matching 1 filter

133,990 assets · 8,802 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
FLUOROURACILUM
Gastric Cancer
I-Mab Biopharma US LimitedP4BB (69)
Calcium folinate pentahydrate
Gastric Cancer
I-Mab Biopharma US LimitedP4BB (68)
Eloxatin
Gastric Cancer
Qilu Pharmaceutical Co., Ltd.P3BB (66)
Irinotecan
Gastric Cancer
Shenzhen Xinhe BiomedicalP4BB (64)
Capecitabine
Gastric Cancer
I-Mab Biopharma US LimitedP3BB (64)
CIS-DIAMMINEDICHLOROPLATINUM II
Gastric Cancer
Qilu Pharmaceutical Co., Ltd.P3BB (64)
Cyclophosphamide
Gastric Cancer
Vall d'Hebron Institute of OncologyP3BB (64)
Docetaxel
Gastric Cancer
Jiangsu Hansoh Pharmaceutical Co., Ltd.P3BB (64)
Epirubicin
Gastric Cancer
Rondo TherapeuticsP3BB (64)
Pembrolizumab
Gastric Cancer
Eikon TherapeuticsP3BB (64)
Carboplatin
Gastric Cancer
Qilu Pharmaceutical Co., Ltd.P2B (59)
FILGRASTIM
Gastric Cancer
Mayo ClinicP2B (59)
Fludarabine
Gastric Cancer
Vall d'Hebron Institute of OncologyP2B (59)
Pyrotinib
Gastric Cancer
BeOne MedicinesP2B (59)
Zanidatamab
Gastric Cancer
Jazz PharmaceuticalsP2B (59)
Ciprofol
Gastric Cancer
RenJi HospitalP4B (58)
PROPOFOL
Gastric Cancer
RenJi HospitalP4B (58)
FLUTICASONE
Gastric Cancer
Mayo ClinicP2B (58)
Nivolumab
Gastric Cancer
I-Mab Biopharma US LimitedP2B (58)
rc48-adc
Gastric Cancer
BeOne MedicinesP2B (58)
Tislelizumab
Gastric Cancer
BeOne MedicinesP2B (58)
Cetuximab
Gastric Cancer
BeOne MedicinesP2B (57)
FULVESTRANT
Gastric Cancer
BeiGeneP2B (57)
Sargramostim
Gastric Cancer
Mayo ClinicP2B (57)
TRASTUZUMAB
Gastric Cancer
Enliven TherapeuticsP2B (57)
Showing 1 to 25 of 220 assets
PreviousPage 1 of 9Next